Literature DB >> 10639213

Clinical Utility of Electrocardiographic ST-Segment Area for Predicting Unsatisfactory Outcomes Following Thrombolytic Therapy.

.   

Abstract

The bedside surface 12-lead electrocardiogram is a mainstay in the early diagnostic evaluation of patients with suspected acute myocardial infarction. The presence of ST-segment elevation exceeding 1.0 mm in two or more anatomically associated leads is a reliable marker of myocardial injury and, when considered along with concomitant ST-segment depression, reflects the extent of myocardial injury. Mounting evidence also suggests that prolonged repolarization is a marker of injury and predicts the likelihood of malignant ventricular arrhythmias. We questioned whether a measure of both ST-segment duration and deviation (ST-deviation area) would offer additional prognostic information. Methods/
Results: Admission electrocardiograms from 200 consecutive patients with ischemic chest pain accompanied by ST-segment elevation in whom thrombolytic therapy was given within 6 hours from symptom onset were analyzed. The sum of ST-segment elevation (Sigma ST elevation) and ST-segment deviation (Sigma ST deviation) were calculated, as was the sum of ST-segment deviation area (Sigma ST deviation area). All ST measurements were performed 60 msec after the J point. Computerized planimetry was used to calculate ST-segment area. Sigma ST deviation and Sigma ST deviation area remained constant over time. Patients with large deviations (Sigma ST elevation > 20 mm (odds ratio 2.14, p = 0.02) and Sigma ST deviation area > 150 (odds ratio 1.92, p = 0.02) had a higher incidence of in-hospital unsatisfactory clinical outcome (defined as death, congestive heart failure, cardiogenic shock, recurrent myocardial infarction, or the need for coronary revascularization). These relationships were present for both inferior and anterior infarctions. Sigma ST deviation area correlated closely with Sigma ST elevation (r = 0.92; p = 0.0001) and significantly but much less strongly with the sum of Q waves (r = 0.18; p = 0.01). By univariate analysis, only site of infarction (p = 0.01), Sigma ST deviation area (p = 0.04), and the sum of Q waves (p = 0.005) were identified as predictors of a poor clinical outcome. The sum of Q waves was identified by multivariate analysis as the best independent predictor of an unsatisfactory clinical outcome. Conclusions: A clinician's ability to provide optimal care is influenced strongly by the availability of diagnostic and prognostic information. In the evaluation of patients with acute myocardial infarction, ST-segment deviation area derived from the admission surface electrocardiogram can be used to risk-stratify patients. The full clinical potential of this measure is unknown and will require further evaluation.

Entities:  

Year:  1995        PMID: 10639213     DOI: 10.1007/bf01063162

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  32 in total

1.  Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

Authors:  R G Wilcox; G von der Lippe; C G Olsson; G Jensen; A M Skene; J R Hampton
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

2.  Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions.

Authors:  P R Maroko; P Libby; J W Covell; B E Sobel; J Ross; E Braunwald
Journal:  Am J Cardiol       Date:  1972-02       Impact factor: 2.778

3.  Precordial ST-segment depression during acute inferior myocardial infarction: clinical, scintigraphic and angiographic correlations.

Authors:  R S Gibson; R S Crampton; D D Watson; G J Taylor; B A Carabello; N D Holt; G A Beller
Journal:  Circulation       Date:  1982-10       Impact factor: 29.690

4.  "Reciprocal" depression of the ST segment in acute myocardial infarction.

Authors:  K Jennings; D S Reid; D G Julian
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-03

5.  Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction. A randomized trial conducted by The Netherlands Interuniversity Cardiology Institute.

Authors:  F W Bar; F Vermeer; C de Zwaan; M Ramentol; S Braat; M L Simoons; W T Hermens; A van der Laarse; F W Verheugt; X H Krauss
Journal:  Am J Cardiol       Date:  1987-01-01       Impact factor: 2.778

6.  Reciprocal ST change in acute myocardial infarction: assessment by electrocardiography and echocardiography.

Authors:  E J Camara; N Chandra; P Ouyang; S H Gottlieb; E P Shapiro
Journal:  J Am Coll Cardiol       Date:  1983-08       Impact factor: 24.094

7.  Impact of the electrocardiogram on the delivery of thrombolytic therapy for acute myocardial infarction.

Authors:  S W Sharkey; C R Berger; D D Brunette; T D Henry
Journal:  Am J Cardiol       Date:  1994-03-15       Impact factor: 2.778

8.  Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group.

Authors: 
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

9.  A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)-Derived Analysis.

Authors:  F Mauri; A P Maggioni; M G Franzosi; C de Vita; E Santoro; L Santoro; P Giannuzzi; G Tognoni
Journal:  J Am Coll Cardiol       Date:  1994-09       Impact factor: 24.094

10.  Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group.

Authors: 
Journal:  JAMA       Date:  1988-11-18       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.